BNC-210
6-(2,3-dihydro-1H-inden-2-ylamino)-1-ethyl-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one
Molecular Identity
BNC-210
6-(2,3-dihydro-1H-inden-2-ylamino)-1-ethyl-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one
PubChem CID: 24772165
2D Structure
Properties
C24H26N4O3
Molecular Formula
418.50
Molecular Weight
g/mol
418.2005
Exact Mass
Da
2.7
XLogP
Drug-like (Lipinski: < 5)
74.8
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
6
H-Bond Acceptors
706
Complexity
SMILES
Canonical SMILES
SMILES: CCN1C=C(C(=O)C2=C1N=CC(=C2)NC3CC4=CC=CC=C4C3)C(=O)N5CCOCC5Isomeric SMILES
SMILES: CCN1C=C(C(=O)C2=C1N=CC(=C2)NC3CC4=CC=CC=C4C3)C(=O)N5CCOCC5Synonyms(20)
SoclenicantBNC-2101020634-41-6QP49AY37OY6-(2,3-dihydro-1H-inden-2-ylamino)-1-ethyl-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-oneRefChem:120828BNC210IW-2143UNII-QP49AY37OY1,8-Naphthyridin-4(1H)-one, 6-((2,3-dihydro-1H-inden-2-yl)amino)-1-ethyl-3-(4-morpholinylcarbonyl)-6-((2,3-Dihydro-1H-inden-2-yl)amino)-1-ethyl-3-(4-morpholinylcarbonyl)-1,8-naphthyridin-4(1H)-onesoclenicant [INN]Soclenicant (USAN/INN)SOCLENICANT [USAN]orb2893720
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to BNC-210
Loading drug network...